Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter

EU orphan designation number: EU/3/14/1412   
Active ingredient: Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter
Indication: Treatment of pancreatic cancer
Sponsor: Karcinolys S.A.S
16 rue de Pervenches, 92500 Rueil-Malmaison, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2015 Orphan designation EMA/OD/187/14 (2015)176 of 15/01/2015